Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Clinical trial NCT06966401 · RECRUITING
Trial details
- NCT number
- NCT06966401
- Sponsor
- Neurocrine Biosciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-16
- Primary completion
- 2029-05-01
- Enrollment
- 850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.